Literature DB >> 12921793

Clinical and genetic heterogeneity in chromosome 9p associated hereditary inclusion body myopathy: exclusion of GNE and three other candidate genes.

Giles D J Watts1, M Thorne, M J Kovach, A Pestronk, Virginia E Kimonis.   

Abstract

We have previously reported a new autosomal dominant inclusion body myopathy clinically resembling limb girdle muscular dystrophy, associated with Paget disease of bone in the majority and frontotemporal dementia in a third of individuals. The critical locus for this unique disorder now termed IBMPFD is 9 p21.1-p12, spans 5.5 Mb and contains the gene responsible for the recessive quadriceps-sparing inclusion body myopathy (IBM2). Mutation analysis of the GNE gene associated with IBM2 in affected individuals from four IBMPFD families did not identify any mutations, indicating that the two disorders are not allelic. Expression studies indicate that GNE has a tissue-specific splice pattern, with four splice variants. Mutation analysis in three other candidate genes (beta-tropomyosin, NDUFB6 and SMU1) did not identify any mutations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921793     DOI: 10.1016/s0960-8966(03)00070-1

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  26 in total

1.  GNE myopathy: new name and new mutation nomenclature.

Authors:  Marjan Huizing; Nuria Carrillo-Carrasco; May Christine V Malicdan; Satoru Noguchi; William A Gahl; Stella Mitrani-Rosenbaum; Zohar Argov; Ichizo Nishino
Journal:  Neuromuscul Disord       Date:  2014-03-13       Impact factor: 4.296

2.  In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Arianna Gomez; Naomi Walker; Hailing Su; Andrew Dunnigan; Marilyn Chwa; Jouni Vesa; M C Kenney; Virginia E Kimonis
Journal:  Mitochondrion       Date:  2015-02-25       Impact factor: 4.160

3.  A progressive translational mouse model of human valosin-containing protein disease: the VCP(R155H/+) mouse.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Mallikarjun Badadani; Hong Z Yin; Christopher Nguyen; Veeral Katheria; Giles Watts; Jogeshwar Mukherjee; Jouni Vesa; Vincent Caiozzo; Tahseen Mozaffar; John H Weiss; Virginia E Kimonis
Journal:  Muscle Nerve       Date:  2012-11-21       Impact factor: 3.217

4.  A cross-sectional analysis of clinical evaluation in 35 individuals with mutations of the valosin-containing protein gene.

Authors:  Jake Plewa; Abhilasha Surampalli; Marie Wencel; Merit Milad; Sandra Donkervoort; Vincent J Caiozzo; Namita Goyal; Tahseen Mozaffar; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2018-06-27       Impact factor: 4.296

5.  A case report comparing clinical, imaging and neuropsychological assessment findings in twins discordant for the VCP p.R155C mutation.

Authors:  Abhilasha Surampalli; Brian T Gold; Charles Smith; Rudy J Castellani; Manaswitha Khare; Hon Yu; Celeste Nguyen; Mary Lan; Marie Wencel; Sharon Wigal; Vince Caiozzo; Virginia Kimonis
Journal:  Neuromuscul Disord       Date:  2014-10-22       Impact factor: 4.296

6.  Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5'UTR and founder allele.

Authors:  Wenhua Zhu; Satomi Mitsuhashi; Takahiro Yonekawa; Satoru Noguchi; Josiah Chai Yui Huei; Atchayaram Nalini; Veeramani Preethish-Kumar; Masayoshi Yamamoto; Kenji Murakata; Madoka Mori-Yoshimura; Sachiko Kamada; Hiroyuki Yahikozawa; Masato Karasawa; Seigo Kimura; Fumitada Yamashita; Ichizo Nishino
Journal:  J Hum Genet       Date:  2016-11-10       Impact factor: 3.172

7.  Radiological features of Paget disease of bone associated with VCP myopathy.

Authors:  Farzin Farpour; Jamshid Tehranzadeh; Sandra Donkervoort; Charles Smith; Barbara Martin; Pari Vanjara; Kathryn Osann; Virginia E Kimonis
Journal:  Skeletal Radiol       Date:  2011-06-04       Impact factor: 2.199

8.  Identification, tissue distribution, and molecular modeling of novel human isoforms of the key enzyme in sialic acid synthesis, UDP-GlcNAc 2-epimerase/ManNAc kinase.

Authors:  Tal Yardeni; Tsering Choekyi; Katherine Jacobs; Carla Ciccone; Katherine Patzel; Yair Anikster; William A Gahl; Natalya Kurochkina; Marjan Huizing
Journal:  Biochemistry       Date:  2011-09-19       Impact factor: 3.162

9.  Biochemical characterization of human and murine isoforms of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE).

Authors:  Stefan O Reinke; Colin Eidenschink; Chris M Jay; Stephan Hinderlich
Journal:  Glycoconj J       Date:  2008-09-23       Impact factor: 2.916

10.  Genotype-phenotype studies of VCP-associated inclusion body myopathy with Paget disease of bone and/or frontotemporal dementia.

Authors:  S G Mehta; M Khare; R Ramani; G D J Watts; M Simon; K E Osann; S Donkervoort; E Dec; A Nalbandian; J Platt; M Pasquali; A Wang; T Mozaffar; C D Smith; V E Kimonis
Journal:  Clin Genet       Date:  2012-10-04       Impact factor: 4.438

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.